Want to see JP:7133 full AI Analyst Report?

HYUGA PRIMARY CARE Co.,Ltd. (7133) Price & Analysis

0 Followers

7133 Stock Chart & Stats

¥1150.00

-¥37.00(-2.91%)

At close: Jan 08 4:00 PM EST

¥1150.00

-¥37.00(-2.91%)

Day’s Range― - ―

52-Week Range¥836.00 - ¥1,593.00

Previous CloseN/A

Volume2.40K

Average Volume (3M)16.77K

Market Cap

¥9.07B

Enterprise Value¥10.17K

Total Cash (Recent Filing)¥1.02B

Total Debt (Recent Filing)¥3.22B

Price to Earnings (P/E)17.7

Beta0.30

Next Earnings

Aug 12, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield1.63%

Share Statistics

EPS (TTM)70.38

Shares Outstanding7,279,000

10 Day Avg. Volume17,690

30 Day Avg. Volume16,766

Financial Highlights & Ratios

PEG Ratio-0.51

Price to Book (P/B)2.84

Price to Sales (P/S)0.65

P/FCF Ratio216.88

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)179.3

Revenue Forecast (FY)¥13.20B

Bulls Say, Bears Say

Bulls Say

Sustained Revenue GrowthConsistent double-digit top-line growth (2026 accelerating to ~16%) shows durable demand for its pharmacy services and expanding scale. That recurring fee-based revenue under Japan's reimbursement framework supports long-term cash flow potential and strategic reinvestment capacity.

High Return On EquityAn ROE near 18% indicates efficient use of shareholder capital and attractive operating profitability versus equity. Sustained ROE supports the firm’s ability to fund growth internally and indicates the underlying business model generates returns above typical capital costs.

Stable, Fee-Based Business ModelThe company's core focus on community pharmacy dispensing and reimbursed service fees creates predictable, contract-like revenue streams. This structural exposure to regulated healthcare payments provides resilience and visibility versus cyclical consumer businesses.

Bears Say

Margin CompressionMeaningful gross and net margin deterioration in 2026 signals rising cost pressures or adverse mix that erode unit economics. Persistent margin weakness would impair free cash flow, reduce reinvestment capacity and weaken the stability of returns even with revenue growth.

Elevated LeverageA debt-to-equity ratio near 1.18x reduces financial flexibility and increases downside risk if profitability stays pressured. Higher leverage can constrain strategic options, raise interest costs and amplify earnings volatility during operational slowdowns.

Weak Cash ConversionSharp deterioration in operating and free cash flow — with OCF covering only ~19% of net income and FCF near breakeven — undermines the quality of reported earnings. Poor cash conversion limits debt paydown, dividends and organic investment over the medium term.

HYUGA PRIMARY CARE Co.,Ltd. News

HYUGA PRIMARY CARE outlines FY2026 results and medium-term outlook

HYUGA PRIMARY CARE Co.,Ltd. ( ($JP:7133) ) has shared an announcement. HYUGA PRIMARY CARE Co., Ltd., a primary...

2M ago

7133

HYUGA PRIMARY CARE Releases Q3 FY2026 Results and Outlook

HYUGA PRIMARY CARE Co.,Ltd. ( ($JP:7133) ) has provided an update. HYUGA PRIMARY CARE has released its financial...

5M ago

7133

7133 FAQ

What was HYUGA PRIMARY CARE Co.,Ltd.’s price range in the past 12 months?

HYUGA PRIMARY CARE Co.,Ltd. lowest stock price was ¥836.00 and its highest was ¥1593.00 in the past 12 months.

What is HYUGA PRIMARY CARE Co.,Ltd.’s market cap?

HYUGA PRIMARY CARE Co.,Ltd.’s market cap is ¥9.07B.

When is HYUGA PRIMARY CARE Co.,Ltd.’s upcoming earnings report date?

HYUGA PRIMARY CARE Co.,Ltd.’s upcoming earnings report date is Aug 12, 2026 which is in 13 days.

How were HYUGA PRIMARY CARE Co.,Ltd.’s earnings last quarter?

HYUGA PRIMARY CARE Co.,Ltd. released its earnings results on May 14, 2026. The company reported ¥35.77 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is HYUGA PRIMARY CARE Co.,Ltd. overvalued?

According to Wall Street analysts HYUGA PRIMARY CARE Co.,Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does HYUGA PRIMARY CARE Co.,Ltd. pay dividends?

HYUGA PRIMARY CARE Co.,Ltd. pays a Notavailable dividend of ¥20 which represents an annual dividend yield of 1.63%. See more information on HYUGA PRIMARY CARE Co.,Ltd. dividends here

What is HYUGA PRIMARY CARE Co.,Ltd.’s EPS estimate?

HYUGA PRIMARY CARE Co.,Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does HYUGA PRIMARY CARE Co.,Ltd. have?

HYUGA PRIMARY CARE Co.,Ltd. has 7,279,000 shares outstanding.

What happened to HYUGA PRIMARY CARE Co.,Ltd.’s price movement after its last earnings report?

HYUGA PRIMARY CARE Co.,Ltd. reported an EPS of ¥35.77 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -11.963%.

Which hedge fund is a major shareholder of HYUGA PRIMARY CARE Co.,Ltd.?

Currently, no hedge funds are holding shares in JP:7133

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

HYUGA PRIMARY CARE Co.,Ltd.

HYUGA PRIMARY CARE Co.,Ltd., established in 2007 and based in Kasuga, Japan, specializes in delivering a variety of primary care services, encompassing home-visit pharmacies, nursing support, and personalized care planning. The company extends its expertise to small and medium-sized pharmacy operators, equipping them with the necessary knowledge, technological systems, staffing solutions, and sales strategies to launch and manage their home visiting pharmacy operations. This includes providing their "Fam Care" home visit support information system, offering on-call system assistance, and guiding them in home palliative care. Furthermore, HYUGA PRIMARY CARE manages "Tai Support," an online platform that aids medical social workers in locating suitable senior housing options, such as assisted living facilities, private nursing homes, and group homes. The firm also develops the "Mimamori ICT Robot Terminal," a wearable device specifically designed for nursing care facilities. In addition to these services, it directly operates its own home visiting pharmacy, delivering prescription medications straight to patients' residences, and plays a significant role in the broader primary care home sector. The company changed its name from Hyuga Pharmacy Co., Ltd. to HYUGA PRIMARY CARE Co.,Ltd. in October 2020.